{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:11:38Z","timestamp":1753884698520,"version":"3.41.2"},"reference-count":48,"publisher":"Open Access Pub","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNRT"],"abstract":"<jats:p>A novel proprietary test formulation was designed which included minerals, vitamins, \u03b2-carotene, cannabidiol isolate,and Panax ginseng extract. This present study was evaluated the impact of the Trivedi Effect\u00ae on novel proprietary test formulation in male Sprague Dawley rats, fed with vitamin D3 deficiency diet (VDD). The novel test formulation was divided into two parts; one part was defined as untreated test formulation, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment by renowned Biofield Energy Healer, Mr. Mahendra Kumar Trivedi. The level of 25-OH Vit. D3 was measured in brain homogenate, which was found to be increased by 20.13%, 24.12%, 45.86%, 14.79%, and 29.96% in the G5 group treated with Biofield Treated test formulation, Biofield Energy Treatment per se to the animals (G6), 15 days pre-treatment of Biofield Energy Treated test formulation (G7), Biofield Energy Treatment per se plus Biofield Energy Treated test formulation from day -15 (G8), and untreated test formulation to the Biofield Energy Treated animals (G9) groups respectively, as compared with the disease control (G2) group. Brain acetylcholine (ACh) level was increased by 61.33% in the G7 group as compared with the untreated test formulation (G4) group. The expression of interleukin-6 (IL-6) was significantly reduced by 43.44% (p\u22640.01), 30.93%, 21.42%, 45.99% (p\u22640.01), and 60.85% (p\u22640.01), respectively as compared with the G4. Lung pro-inflammatory cytokine tumor necrosis factor alpha (TNF-\u03b1) level was significantly reduced in the G5, G6, G7, and G8 by 24.86%, 32.55% (p\u22640.01), 30.12% (p\u22640.01), and 42.69% (p\u22640.01), respectively, as compared with the G4 group. Altogether, the Biofield Treated test formulation and\/or per se treatment to the animals significantly improved the levels of active form of vitamin D3 metabolite (25-OH Vit D3) and neurotransmitter (ACh); consequently significantly lowered the expression of proinflammatory cytokines (IL-6 and TNF-\u03b1). Therefore, the energized test formulation or per se treatment could be effectively useful against neuronal damage and inflammation for the management of brain disorders such as Alzheimer\u2019s disease, dementias, brain cancer, epilepsy and other seizure disorders, mental disorders, and Parkinson\u2019s. Thus, the results showed a significant slowdown of disease progression and all other disease-related complications\/symptoms in the preventive Biofield Energy Treatment group per se and the Biofield Energy Treated Test formulation groups (viz. G6, G7, G8, and G9) as compared to the disease control group.<\/jats:p>","DOI":"10.14302\/issn.2470-5020.jnrt-21-3755","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T05:04:06Z","timestamp":1620104646000},"page":"1-11","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Vitamin D3 metabolite (25-OH Vit D3), Neurotransmitter (ACh), and the Expression of Proinflammatory Cytokines (IL-6 and TNF-\u03b1) in Tissue Homogenate after Administration of Biofield Energy Healing-based Novel Proprietary Test Formulation and Biofield Treatment per se to the Animals in Vitamin D3 Deficiency Diet (VDD)-induced Sprague Dawley Rats"],"prefix":"10.14302","volume":"3","author":[{"given":"Mahendra Kumar","family":"Trivedi","sequence":"first","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Alice","family":"Branton","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Dahryn","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, Nevada, USA"}]},{"given":"Snehasis","family":"Jana","sequence":"additional","affiliation":[{"name":"Trivedi Science Research Laboratory Pvt. Ltd., Thane (W), Maharashtra, India"}]}],"member":"5410","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L et al. (2010) A meta-analysis of cytokines in major depression. , Biol Psychiatry 67, 446-457.","DOI":"10.1016\/j.biopsych.2009.09.033"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.Morales I, Farias G, Maccioni R B. (2010) Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. , Neuroimmunomodulation 17, 202-204.","DOI":"10.1159\/000258724"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.McAfoose J, Baune B T. (2009) Evidence for a cytokine model of cognitive function. , Neurosci Biobehav Rev 33, 355-366.","DOI":"10.1016\/j.neubiorev.2008.10.005"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.Kim J M, Stewart R, Kim S W, Shin I S, Kim J T et al. (2011) Associations of cytokine gene polymorphisms with post-stroke depression. , World J Biol Psychiatry, Yoon JS","DOI":"10.3109\/15622975.2011.588247"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.Baune B T, Rothermundt M, Ladwig K H, Meisinger C, Berger K. (2011) Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: Results from a 9-year follow-up of the MEMO Study. , Age (Dordr) 33, 209-217.","DOI":"10.1007\/s11357-010-9165-5"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.Tancredi V, D'Antuono M, Cafe C, Giovedi S, Bue M C et al. (2000) The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. , J Neurochem 75, 634-643.","DOI":"10.1046\/j.1471-4159.2000.0750634.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.Peng Y P, Qiu Y H, Lu J H, Wang J J. (2005) Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. , Neurosci Lett 374, 192-196.","DOI":"10.1016\/j.neulet.2004.10.069"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.Brietzke E, Stertz L, Fernandes B S, Kauer-Sant'anna M, Mascarenhas M et al. (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. , J Affect Disord 116, 214-217.","DOI":"10.1016\/j.jad.2008.12.001"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.Tilg H, Dinarello C A, Mier J W. (1997) IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. , Immunol Today 18, 428-432.","DOI":"10.1016\/s0167-5699(97)01103-1"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.Lionetto M G, Caricato R, Calisi A, Giordano M E, Schettino T. (2013) Acetylcholinesterase as a biomarker in environmental and occupational medicine: New insights and future perspectives. BioMed Research International 2013, Article ID 321213 8.","DOI":"10.1155\/2013\/321213"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.Gooch C L. (2014) . , Neuromuscular Junction, Normal, Encyclopedia of the Neurological Sciences (Second Edition) 423-424.","DOI":"10.1016\/b978-0-12-385157-4.00638-2"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.Durieux E D, Farver T B, Fitzgerald P S, Eder K J, Ostrach D J. (2011) Natural factors to consider when using acetylcholinesterase activity as neurotoxicity biomarker in Young-Of-Year striped bass (Moronesaxatilis). , Fish Physiol Biochem 37(1), 21-9.","DOI":"10.1007\/s10695-010-9412-9"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.C. (2010) The cure of ageing: Vitamin D\u2013magic or myth?. , Postgrad Med J 86, 608-616.","DOI":"10.1136\/pgmj.2010.101121"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.Mangelsdorf D J, Thummel C, Beato M, Herrlich P, Sch\u00fctz G et al. (1995) The nuclear receptor superfamily: The second decade. , Evans RM, Cell 83(6), 835-9.","DOI":"10.1016\/0092-8674(95)90199-x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.Calabresi P, Castrioto A, M Di Filippo, Picconi B. (2013) New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. , Lancet Neurol 12(8), 811-21.","DOI":"10.1016\/s1474-4422(13)70118-2"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.Zhao X, Fan W, Xu Z, Chen H, He Y et al. (2016) Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma. , Oncotarget 7, 81110-22.","DOI":"10.18632\/oncotarget.13212"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.Li Q, Zheng X. (2017) Tumor necrosis factor alpha is a promising circulating biomarker for the development of obstructive sleep apnea syndrome: A meta-analysis. , Oncotarget 8(16), 27616-27626.","DOI":"10.18632\/oncotarget.15203"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.Byrne J H, Voogt M, Turner K M, Eyles D W, McGrath J J et al. (2013) The impact of adult vitamin D deficiency on behaviour and brain function in male Sprague-Dawley rats. , PLoS One 8(8), 71593.","DOI":"10.1371\/journal.pone.0071593"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.Rayman M P. (2000) The importance of selenium to human health. , Lancet 356, 233-241.","DOI":"10.1016\/S0140-6736(00)02490-9"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.Beard J L, Connor J R. (2003) Iron status and neural functioning. , Ann Rev Nutr 23, 41-58.","DOI":"10.1146\/annurev.nutr.23.020102.075739"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.Peres F F, Lima A C, JEC Hallak, Crippa J A, Silva R H.Ab\u00edlio VC (2018) Cannabidiol as a promising strategy to treat and prevent movement disorders?. , Front Pharmacol 9, 482.","DOI":"10.3389\/fphar.2018.00482"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.Nagarkatti P, Pandey R, Rieder S A, Hegde V L, Nagarkatti M. (2009) Cannabinoids as novel anti-inflammatory drugs. , Future Med Chem 1(7), 1333-1349.","DOI":"10.4155\/fmc.09.93"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.Kang S, Min H. (2012) Ginseng, the 'Immunity Boost': The effects ofPanax ginsengon immune system. , J Ginseng Res 36(4), 354-368.","DOI":"10.5142\/jgr.2012.36.4.354"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.Maizes V, Rakel D, Niemiec C. (2009) Integrative medicine and patient-centered care. , Explore (NY) 5(5), 277-289.","DOI":"10.1016\/j.explore.2009.06.008"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.Bischof M, Del Giudice E. (2013) Communication and the emergence of collective behavior in living organisms: A quantum approach. Mol Biol Int. 987549.","DOI":"10.1155\/2013\/987549"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.Cassidy C M. (2004) What does it mean to practice an energy medicine?. , J Altern Complement Med 10(1), 79-81.","DOI":"10.1089\/107555304322848986"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.Barnes P M, Bloom B, Nahin R L. (2008) Complementary and alternative medicine use among adults and children: United States. , Natl Health Stat Report 12, 1-23.","DOI":"10.1037\/e623942009-001"},{"key":"ref27","unstructured":"28.Fan K wai. (2005) National Center for Complementary and Alternative Medicine Website. , J Med Libr Assoc 93, 410-412."},{"key":"ref28","unstructured":"29.Wisneski L, Anderson L. (2009) The Scientific Basis of Integrative Medicine. , Boca Raton, FL: 205."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.Trivedi M K, Tallapragada R M. (2008) A transcendental to changing metal powder characteristics. , Met Powder Rep 63, 22-28.","DOI":"10.1016\/s0026-0657(08)70145-0"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.Trivedi M K, Nayak G, Patil S, Tallapragada R M, Latiyal O. (2015) Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment. , Ind Eng Manage 4, 161.","DOI":"10.4172\/2169-0316.1000161"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.Trivedi M K, Branton A, Trivedi D, Nayak G, Mondal S C et al. (2015) Morphological characterization, quality, yield and DNA fingerprinting of biofield energy treated alphonso mango (Mangifera indicaL.). , Journal of Food and Nutrition Sciences 3, 245-250.","DOI":"10.11648\/j.jfns.20150306.18"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.Trivedi M K, Branton A, Trivedi D, Nayak G, Charan S et al. (2015) Phenotyping and 16S rDNA analysis after biofield treatment onCitrobacterbraakii: A urinary pathogen. , J Clin Med Genom 3, 129.","DOI":"10.4172\/2332-0672.1000129"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.Trivedi M K, Patil S, Shettigar H, Mondal S C, Jana S. (2015) Evaluation of biofield modality on viral load of Hepatitis B and C viruses. , J Antivir Antiretrovir 7, 083-088.","DOI":"10.4172\/jaa.1000123"},{"key":"ref34","unstructured":"35.Nayak G, Altekar N. (2015) Effect of biofield treatment on plant growth and adaptation. , J Environ Health Sci 1, 1-9."},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.Branton A, Jana S. (2017) The influence of energy of consciousness healing treatment on low bioavailable resveratrol in maleSprague Dawleyrats. , International Journal of Clinical and Developmental Anatomy 3, 9-15.","DOI":"10.11648\/j.ijcda.20170303.11"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.Branton A, Jana S. (2017) The use of novel and unique biofield energy healing treatment for the improvement of poorly bioavailable compound, berberine in maleSprague Dawleyrats. , American Journal of Clinical and Experimental Medicine 5, 138-144.","DOI":"10.11648\/j.ajcem.20170504.16"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.Kinney J P, Trivedi M K, Branton A, Trivedi D, Nayak G et al. (2017) Overall skin health potential of the biofield energy healing based herbomineral formulation using various skin parameters. , American Journal of Life Sciences 5, 65-74.","DOI":"10.11648\/j.ajls.20170502.15"},{"key":"ref38","unstructured":"39.Singh J, Trivedi M K, Branton A, Trivedi D, Nayak G et al. (2017) Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health. , American Journal of Pharmacology and Phytotherapy 2, 1-10."},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40.Trivedi M K, Branton A, Trivedi D, Nayak G, Plikerd W D et al. (2017) A systematic study of the biofield energy healing treatment on physicochemical, thermal, structural, and behavioral properties of magnesium gluconate. , International Journal of Bioorganic Chemistry 2, 135-145.","DOI":"10.11648\/j.ijnfs.20170602.13"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41.Trivedi M K, Patil S, Shettigar H, Mondal S C, Jana S. (2015) The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy. , J Integr Oncol 4, 141.","DOI":"10.4172\/2329-6771.1000141"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42.Anagnos D, Trivedi K, Branton A, Trivedi D, Nayak G et al. (2018) Influence of biofield treated vitamin D3on proliferation, differentiation, and maturation of bone-related parameters in MG-63 cell-line. , International Journal of Biomedical Engineering and Clinical Science 4, 6-14.","DOI":"10.11648\/j.ijbecs.20180401.12"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43.Lee A C, Trivedi K, Branton A, Trivedi D, Nayak G et al. (2018) The potential benefits of biofield energy treated vitamin D3on bone mineralization in human bone osteosarcoma cells (MG-63). , International Journal of Nutrition and Food Sciences 7, 30-38.","DOI":"10.11648\/j.ijnfs.20180701.15"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44.Alshishtawy M M. (2012) Vitamin D Deficiency: This clandestine endemic disease is veiled no more. , Sultan Qaboos Univ Med J 12(2), 140-152.","DOI":"10.12816\/0003106"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45.Ritu G, Gupta A. (2014) Vitamin D deficiency in India: Prevalence, causalities and interventions. , Nutrients 6(2), 729-775.","DOI":"10.3390\/nu6020729"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46.Colovi\u0107 M B, Krsti\u0107 D Z, Lazarevi\u0107-Pa\u0161ti T D, Bond\u017ei\u0107 A M, Vasi\u0107 V M. (2013) Acetylcholinesterase inhibitors: Pharmacology and toxicology. , Curr Neuropharmacol 11(3), 315-335.","DOI":"10.2174\/1570159x11311030006"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"47.Tanaka T, Narazaki M, Kishimoto T. (2014) IL-6 in inflammation, immunity, and disease. , Cold Spring Harb Perspect Biol 6(10), 016295.","DOI":"10.1101\/cshperspect.a016295"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48.Yang T, Li Y, Lyu Z. (2017) Characteristics of proinflammatory cytokines and chemokines in airways of asthmatics: Relationships with disease severity and infiltration of inflammatory cells. , Chin Med J (Engl) 130(17), 2033-2040.","DOI":"10.4103\/0366-6999.213428"}],"container-title":["Journal of Neurological Research and Therapy"],"original-title":[],"link":[{"URL":"https:\/\/openaccesspub.org\/jnrt\/article\/1595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T05:04:20Z","timestamp":1620104660000},"score":1,"resource":{"primary":{"URL":"https:\/\/openaccesspub.org\/jnrt\/article\/1595"}},"subtitle":[],"editor":[{"given":"Sasho","family":"Stoleski","sequence":"additional","affiliation":[{"name":"Institute of Occupational Health of R. Macedonia, WHO CC and Ga2len CC, Macedonia."}]}],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,3,13]]}},"URL":"https:\/\/doi.org\/10.14302\/issn.2470-5020.jnrt-21-3755","relation":{},"ISSN":["2470-5020"],"issn-type":[{"type":"electronic","value":"2470-5020"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"article-number":"1595"}}